MDwise said it could not reach an agreement with the Indiana Family and Social Services Administration’s Office of Medicaid Policy and Planning over payment rates for the Hoosier Care Connect program.
The meeting between the president and U.S. health insurers on Monday was a chance for the industry to weigh in on promised changes to the Affordable Care Act that are beginning to come into focus.
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Politico has reported that the Trump White House was not impressed with a 2016 column in which local Republican strategist Marcus Barlow said Trump was “offensive and ignorant” but not a racist.
The county-owned hospital system has more than $100 million in ongoing projects, making it one of the biggest eras of growth in the history of Riverview, which opened its Noblesville hospital in 1951.
Doubters about the $48 billion Anthem-Cigna merger have been in abundance from the start—both on antitrust grounds and on concerns over cultural fit.
Indiana House Republicans are taking the unusual step of reassigning an abortion bill to the same panel that narrowly approved it last week.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
Cigna Corp. and Anthem Inc. are trading accusations of harassment and sabotage in competing lawsuits as the two health companies feud publicly in the wake of a stalled $48 billion merger.
Indiana health care consulting executive Seema Verma on Thursday testified before the Senate Finance Committee on her nomination to lead the Centers for Medicare and Medicaid Services, or CMS.
Baldwin & Lyon’s said gross premiums written during the fourth quarter totaled a record $104.9 million, 7.2 percent higher than the fourth quarter of 2015.
Indianapolis-based Anthem Inc. on Wednesday won a court ruling blocking Cigna Corp. from terminating a proposed merger between the health insurers until a judge could weigh arguments over the faltering deal at an April 10 hearing.
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
In the lawsuit, Anthem blasted Cigna, accusing it of repeated efforts to sabotage their proposed merger.
The collapse of one potential mega-merger and the uncertain future of the other could hurt shoppers on the Affordable Care Act exchanges next year by leaving them with even fewer options and potentially higher prices.
A review by The Associated Press found Seema Verma and her small Indianapolis-based firm made millions through consulting agreements with at least nine states while also working under contract for Hewlett Packard.
Indianapolis-based Anthem responded almost immediately Tuesday by saying Cigna does not have the right to cancel the deal.
The Humana-Aetna deal was one of two mergers that would have reshaped the U.S. health insurance landscape. Both were rejected by federal judges as anticompetitive. Anthem hasn't given up on its deal—a $48 billion pact to acquire Cigna—and is pressing ahead with an appeal.
Two local men who have been working on a potential blockbuster treatment for a rare and debilitating disease are hopeful that a major injection of venture capital will provide the boost needed to move the drug to market—even if it means sweeping changes for their company.
Anthem filed a notice of appeal on Thursday after a federal judge blocked its $48 billion deal to buy Cigna Corp.
